The effectiveness of tyrosine kinase inhibitor for chronic myeloid leukemia in tuberous sclerosis. A case report and review of literature

The effectiveness of tyrosine kinase inhibitor for chronic myeloid leukemia in tuberous sclerosis. A case report and review of literature

Abstract The relationship between chronic myelogenous leukemia (CML) and tuberous sclerosis (TS) is unusual and uncommon. Here, we report a 24‐year‐old woman diagnosed with TS and later identified with CML, as the second case reported with such coexistence, treated with Nilotinib. This article propo...

Full description

Bibliographic Details
Main Authors: Abdulrahman Al‐Abdulmalek, Reem Al‐Suliman, Mohammad Abu‐Tineh, Mostafa Ali, Mohamed A. Yassin
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:Clinical Case Reports
Subjects:
CML
tuberous sclerosis
tyrosine kinase inhibitors
Online Access:https://doi.org/10.1002/ccr3.7087

Similar Items

Similar Items